Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702617 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
A negative round of targeted biopsies does not exclude clinically significant PCa in men with highly suspicious mpMRI findings. Patients with imaging-pathology disagreement should be carefully reviewed and considered for repeat biopsy or for strict surveillance.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel N. M.D., Fernando U. M.D., Ivan M.D., Lauren Kolski, Yair M.D., Claus G. M.D., Brad M.P.A.S., Yin Ph.D., Franto M.D., Neil M. M.D.,